Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 4,212,346 5.400% | -3,160,882 (-42.87%) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | REGULUS THERAPEUTICS INC P RGLS | BIOTECHNOLOGY VALUE FUND L P | 883,844 1.300% | -82,280 (-8.52%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -334,795 (Position Closed) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | 89BIO INC ETNB | BIOTECHNOLOGY VALUE FUND L P | 6,811,631 6.400% | -756,849 (-10.00%) | Filing History |
| 2024-11-14 4:29 pm Sale | 2024-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,563,963 (Position Closed) | Filing History |
| 2024-11-14 4:29 pm Purchase | 2024-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | BIOTECHNOLOGY VALUE FUND L P | 1,047,123 9.990% | 700,100 (+201.74%) | Filing History |
| 2024-11-14 4:28 pm Purchase | 2024-09-30 | 13G | ELEVATION ONCOLOGY INC ELEV | BIOTECHNOLOGY VALUE FUND L P | 6,230,845 9.990% | 1,779,960 (+39.99%) | Filing History |
| 2024-11-14 4:27 pm Sale | 2024-09-30 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 2,970,427 4.900% | -2,793,521 (-48.47%) | Filing History |
| 2024-11-14 4:27 pm Sale | 2024-09-30 | 13G | ZYMEWORKS INC ZYME | BIOTECHNOLOGY VALUE FUND L P | 4,607,935 6.500% | -1,262,065 (-21.50%) | Filing History |
| 2024-11-14 4:26 pm Purchase | 2024-09-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% | 1,386,906 (+20.69%) | Filing History |
| 2024-11-14 4:26 pm Sale | 2024-09-30 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -24,435,632 (Position Closed) | Filing History |
| 2024-11-14 4:24 pm Purchase | 2024-09-30 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 5,796,433 9.990% | 1,403,112 (+31.94%) | Filing History |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | JANUX THERAPEUTICS INC JANX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -4,579,818 (Position Closed) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,409,993 1.700% | -2,069,050 (-59.47%) | Filing History |
| 2024-11-14 4:22 pm Purchase | 2024-09-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 703,126 9.990% | 239,350 (+51.61%) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | DELCATH SYS INC DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,041,667 3.600% | -1,296,759 (-55.45%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -8,774,570 (Position Closed) | Filing History |
| 2024-11-13 4:08 pm Purchase | 2024-09-30 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 7,382,642 14.200% | 3,375,229 (+84.22%) | Filing History |
| 2024-11-12 5:27 pm Sale | 2024-11-07 | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 2,372,933 5.300% | -1,993,000 (-45.65%) | Filing History |
| 2024-11-01 4:27 pm Purchase | 2024-10-25 | 13G | SEPTERNA INC SEPN | BIOTECHNOLOGY VALUE FUND L P | 2,452,024 5.500% | 2,452,024 (New Position) | Filing History |